ProKidney Corp. Class A Ordinary Shares
PROK KYG7S53R1049
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Weber Darin J. SR OFF |
3.02 USD |
103,480 Sold |
312,510 USD |
08/07/2025 | 08/07/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.71 USD |
387,393 Bought |
276,366 USD |
22/04/2025 | 22/04/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.75 USD |
25,000 Bought |
18,690 USD |
17/04/2025 | 17/04/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.75 USD |
100,000 Bought |
74,820 USD |
16/04/2025 | 16/04/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.70 USD |
468,000 Bought |
326,009 USD |
14/04/2025 | 15/04/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.73 USD |
268,105 Bought |
194,591 USD |
14/04/2025 | 14/04/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.61 USD |
1,900 Bought |
1,155 USD |
10/04/2025 | 11/04/2025 |
| Control Empresarial De Capitales S.a. De C.v. |
0.61 USD |
1,032,218 Bought |
627,692 USD |
10/04/2025 | 10/04/2025 |
| Weber Darin J. SR OFF |
2.50 USD |
16,412 Sold |
41,030 USD |
19/09/2024 | 19/09/2024 |
| Weber Darin J. SR OFF |
2.50 USD |
826 Sold |
2,065 USD |
26/07/2024 | 26/07/2024 |